These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8369576)

  • 41. Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study.
    Marsili F; Travaglini M; Stinco G; Manzoni R; Tiberio R; Prignano F; Mazzotta A; Cannavò SP; Cuccia A; Germino M; Bongiorno MR; Persechino S; Florio T; Pettinato M; Tabanelli M; Sarkar R; Aloisi E; Bartezaghi M; Orsenigo R
    J Dermatolog Treat; 2022 Feb; 33(1):401-407. PubMed ID: 32349568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
    Pedraz J; Daudén E; Delgado-Jiménez Y; García-Río I; García-Díez A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.
    Corrocher G; Di Lorenzo G; Mansueto P; Martinelli N; Esposito-Pellitteri M; Gelio S; Lombardo G; Pacor ML
    Clin Ther; 2006 Sep; 28(9):1296-302. PubMed ID: 17062302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris.
    Karakawa M; Komine M; Takekoshi T; Sakurai N; Minatani Y; Tada Y; Saeki H; Tamaki K
    J Dermatol; 2011 Jul; 38(7):655-60. PubMed ID: 21352300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation.
    Di Gioacchino M; Di Stefano F; Cavallucci E; Verna N; Ramondo S; Paolini F; Caruso R; Schiavone C; Masci S; Santucci B; Paganelli R; Conti P
    Allergy Asthma Proc; 2003; 24(4):285-90. PubMed ID: 12974197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure.
    Zver S; Zupan IP; Cernelc P
    Int J Hematol; 2006 Apr; 83(3):238-42. PubMed ID: 16720554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
    Ito T; Furukawa F; Iwatsuki K; Matsue H; Shimada S; Takigawa M; Tokura Y
    J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis.
    Svarstad E; Helland S; Morken T; Bostad L; Myking A; Iversen BM; Ofstad J
    Nephrol Dial Transplant; 1994; 9(10):1462-7. PubMed ID: 7816261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative non randomized study of narrow-band (NB) (312 +/- 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin A and NB-UVB phototherapy in patients with severe psoriasis vulgaris.
    Calzavara-Pinton P; Leone G; Venturini M; Sala R; Colombo D; La Parola IL; Sitzia N; Ferraro C; Picardo M
    Eur J Dermatol; 2005; 15(6):470-3. PubMed ID: 16280301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical usefulness of a supplementary cyclosporin administration with a topical application of maxacalcitol ointment for patients with moderate psoriasis vulgaris.
    Abe M; Syuto T; Hasegawa M; Yokoyama Y; Ishikawa O
    J Dermatol; 2009 Apr; 36(4):197-201. PubMed ID: 19348657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
    Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term, drug-free remission of sympathetic ophthalmia with high-dose, short-term chlorambucil therapy.
    Patel SS; Dodds EM; Echandi LV; Couto CA; Schlaen A; Tessler HH; Goldstein DA
    Ophthalmology; 2014 Feb; 121(2):596-602. PubMed ID: 24572676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short- and long-term efficacy of cyclosporin administration in patients with acute severe ulcerative colitis. Belgian IBD Group.
    Van Gossum A; Schmit A; Adler M; Chioccioli C; Fiasse R; Louwagie P; D'Haens G; Rutgeerts P; De Vos M; Reynaert H; Devis G; Belaiche J; Van Outryve M
    Acta Gastroenterol Belg; 1997; 60(3):197-200. PubMed ID: 9396174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood concentrations and clinical effect of cyclosporin in psoriasis.
    Furlanut M; Baraldo M; Pea F; Marzocchi V; Croattino L; Galla F
    Ther Drug Monit; 1996 Oct; 18(5):544-8. PubMed ID: 8885117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis.
    Wagner SA; Peter RU; Adam O; Ruzicka T
    Dermatology; 1993; 186(1):62-7. PubMed ID: 8435521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis.
    Bamba S; Tsujikawa T; Inatomi O; Nakahara T; Koizumi Y; Saitoh Y; Sasaki M; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2010 Mar; 25(3):494-8. PubMed ID: 20370728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study.
    Cannavò SP; Guarneri F; Vaccaro M; Borgia F; Guarneri B
    Dermatology; 2003; 206(2):153-6. PubMed ID: 12592084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.